Tang, T., Wang, G., Liu, S., Zhang, Z., Liu, C., Li, F., . . . Zhao, L. (2021). Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis. Nature Portfolio.
Chicago Style (17th ed.) CitationTang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.
MLA (8th ed.) CitationTang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.